IMCD N.V [IMCD] vs DSM-Firmenich AG [DSFIR] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 19 vital metrics comparison: IMCD N.V. wins in 10 metrics, DSM-Firmenich AG wins in 9 metrics, with 0 ties. IMCD N.V. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | IMCD N.V. | DSM-Firmenich AG | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 26.18 | 53.42 | IMCD N.V. |
| Price-to-Book Ratio | 2.79 | 0.89 | DSM-Firmenich AG |
| Debt-to-Equity Ratio | 87.66 | 28.64 | DSM-Firmenich AG |
| PEG Ratio | -0.28 | 16.15 | DSM-Firmenich AG |
| EV/EBITDA | 14.34 | 13.78 | DSM-Firmenich AG |
| Profit Margin (TTM) | 4.53% | -11.97% | IMCD N.V. |
| Operating Margin (TTM) | 7.28% | 6.96% | IMCD N.V. |
| EBITDA Margin (TTM) | 7.28% | 6.96% | IMCD N.V. |
| Return on Equity | 10.22% | 1.66% | IMCD N.V. |
| Return on Assets (TTM) | 5.18% | 1.25% | IMCD N.V. |
| Free Cash Flow (TTM) | $301.98M | $651.00M | DSM-Firmenich AG |
| Dividend Yield | 1.91% | 2.63% | DSM-Firmenich AG |
| 1-Year Return | -24.55% | 21.98% | DSM-Firmenich AG |
| Price-to-Sales Ratio (TTM) | 1.18 | 1.79 | IMCD N.V. |
| Enterprise Value | $7.24B | $19.81B | DSM-Firmenich AG |
| EV/Revenue Ratio | 1.51 | 2.19 | IMCD N.V. |
| Revenue per Share (TTM) | $81 | $35 | IMCD N.V. |
| Earnings per Share (Diluted) | $3.68 | $1.21 | IMCD N.V. |
| Beta (Stock Volatility) | 0.95 | 0.52 | DSM-Firmenich AG |
IMCD N.V. vs DSM-Firmenich AG Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| IMCD N.V. | 0.23% | 1.86% | -7.50% | 20.65% | 15.92% | 13.58% |
| DSM-Firmenich AG | -0.46% | 10.60% | 11.30% | 17.12% | 17.12% | 17.12% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| IMCD N.V. | -24.55% | -34.77% | -33.07% | 147.61% | 296.16% | 296.16% |
| DSM-Firmenich AG | 21.98% | 21.98% | 21.98% | 21.98% | 21.98% | 21.98% |
Performance & Financial Health Analysis: IMCD N.V. vs DSM-Firmenich AG
| Metric | IMCD | DSFIR |
|---|---|---|
| Market Information | ||
| Market Cap | €5.68B | €16.17B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 287,067 | 736,488 |
| 90 Day Avg. Volume | 346,933 | 830,232 |
| Last Close | €88.82 | €73.46 |
| 52 Week Range | €68.14 - €118.00 | €55.22 - €96.60 |
| % from 52W High | -24.73% | -23.95% |
| All-Time High | €211.30 (Dec 06, 2021) | €124.85 (Sep 30, 2024) |
| % from All-Time High | -57.96% | -41.16% |
| Growth Metrics | ||
| Quarterly Revenue Growth | -0.02% | N/A |
| Quarterly Earnings Growth | -0.36% | N/A |
| Financial Health | ||
| Profit Margin (TTM) | 0.05% | -0.12% |
| Operating Margin (TTM) | 0.07% | 0.07% |
| Return on Equity (TTM) | 0.10% | 0.02% |
| Debt to Equity (MRQ) | 87.66 | 28.64 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | €34.57 | €72.53 |
| Cash per Share (MRQ) | €4.04 | €7.57 |
| Operating Cash Flow (TTM) | €322.28M | €1.44B |
| Levered Free Cash Flow (TTM) | €303.50M | €-32,125,000 |
| Dividends | ||
| Last 12-Month Dividend Yield | 1.91% | 2.63% |
| Last 12-Month Dividend | €2.15 | €2.50 |
Valuation & Enterprise Metrics Analysis: IMCD N.V. vs DSM-Firmenich AG
| Metric | IMCD (Apr 24, 2026) | DSFIR (Apr 24, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 26.18 | 53.42 |
| Forward P/E | 15.71 | 16.15 |
| PEG Ratio | -0.28 | 16.15 |
| Price to Sales (TTM) | 1.18 | 1.79 |
| Price to Book (MRQ) | 2.79 | 0.89 |
| Market Capitalization | ||
| Market Capitalization | €5.68B | €16.17B |
| Enterprise Value | €7.24B | €19.81B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 1.51 | 2.19 |
| Enterprise to EBITDA | 14.34 | 13.78 |
| Risk & Other Metrics | ||
| Beta | 0.95 | 0.52 |
| Book Value per Share (MRQ) | €34.57 | €72.53 |
Financial Statements Comparison: IMCD N.V. vs DSM-Firmenich AG
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | IMCD (2025) | DSFIR (2025) |
|---|---|---|
| Revenue/Sales | 4.78B | 9.03B |
| Cost of Goods Sold | 3.59B | 5.50B |
| COGS % of Revenue | 75.0% | 60.9% |
| Gross Profit | 1.19B | 3.53B |
| Gross Margin | 25.0% | 39.1% |
| Research & Development | N/A | 713.00M |
| Operating Income (EBIT) | 371.25M | 632.00M |
| Operating Margin | 7.8% | 7.0% |
| EBITDA | 490.09M | 3.76B |
| EBITDA Margin | 10.3% | 41.6% |
| Pre-Tax Income | 291.13M | 568.00M |
| Pre-Tax Income % of Revenue | 6.1% | 6.3% |
| Income Tax | 73.63M | 118.00M |
| Income Tax % of Revenue | 1.5% | 1.3% |
| Net Income (Profit) | 217.50M | -1.04B |
| Profit Margin | 4.6% | -11.5% |
Balance Sheet & Liquidity Metrics
| Metric | IMCD (2025) | DSFIR (2025) |
|---|---|---|
| Cash & Equivalents | 236.09M | 1.78B |
| Total Current Assets | 1.80B | 8.89B |
| Total Current Assets % of Revenue | 37.6% | 98.4% |
| Total Current Liabilities | 1.03B | 5.59B |
| Total Current Liabilities % of Revenue | 21.7% | 61.9% |
| Long-Term Debt | 1.37B | 3.62B |
| Long-Term Debt % of Revenue | 28.6% | 40.0% |
| Total Shareholders Equity | 2.04B | 18.42B |
| Retained Earnings | 1.00B | 8.41B |
| Retained Earnings % of Revenue | 21.0% | 93.0% |
| Property, Plant & Equipment | 21.76M | 0 |
Cash Flow Statement Comparison
| Metric | IMCD (2025) | DSFIR (2025) |
|---|---|---|
| Operating Cash Flow | 250.10M | -1.15B |
| Operating Cash Flow % of Revenue | 5.2% | -12.7% |
| Capital Expenditures | -13.04M | 34.00M |
| Free Cash Flow | 301.98M | 651.00M |
| FCF Margin | 6.3% | 7.2% |
| Debt Repayment | -559.95M | -1.34B |
| Common Stock Repurchase | -6.20M | -1.18B |
Short Interest & Institutional Ownership Analysis
| Metric | IMCD | DSFIR |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 59.03M | 251.53M |
| Float Shares | 51.35M | 235.20M |
| % Held by Insiders | 2.64% | 9.49% |
| % Held by Institutions | 88.24% | 32.21% |
| % Held by Public | 9.12% | 58.30% |
Dividend Analysis & Yield Comparison: IMCD N.V. vs DSM-Firmenich AG
| Metric | IMCD | DSFIR |
|---|---|---|
| Last 12-Month Dividend | €2.15 | €2.50 |
| Last 12-Month Dividend Yield | 1.91% | 2.63% |
| 3-Year Avg Annual Dividend | €2.25 | €2.20 |
| 3-Year Avg Dividend Yield | 1.71% | 2.22% |
| 3-Year Total Dividends | €6.76 | €6.60 |
| Ex-Dividend Date | Apr 29, 2025 | May 08, 2025 |